DE69812347D1 - Zusammensetzungen zur verstärkung der pharmakologischen aktivität von immunosuppressiva - Google Patents

Zusammensetzungen zur verstärkung der pharmakologischen aktivität von immunosuppressiva

Info

Publication number
DE69812347D1
DE69812347D1 DE69812347T DE69812347T DE69812347D1 DE 69812347 D1 DE69812347 D1 DE 69812347D1 DE 69812347 T DE69812347 T DE 69812347T DE 69812347 T DE69812347 T DE 69812347T DE 69812347 D1 DE69812347 D1 DE 69812347D1
Authority
DE
Germany
Prior art keywords
compositions
rapamycin
site
immunosuppressiva
strengthening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69812347T
Other languages
English (en)
Other versions
DE69812347T9 (de
DE69812347T2 (de
Inventor
Vladimir Petrovich Zavialov
Raisa Nikolaevna Vasilenko
Dmitry Aleksandrovich Dolgikh
Mikhail Petrovich Kirpichnikov
Elena Vitalievna Navolotskaya
Timo Kalevi Korpela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69812347D1 publication Critical patent/DE69812347D1/de
Publication of DE69812347T2 publication Critical patent/DE69812347T2/de
Publication of DE69812347T9 publication Critical patent/DE69812347T9/de
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69812347T 1997-05-19 1998-05-18 Zusammensetzungen zur verstärkung der pharmakologischen aktivität von immunosuppressiva Expired - Fee Related DE69812347T9 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI972121 1997-05-19
FI972121A FI104363B (fi) 1997-05-19 1997-05-19 Immunosuppressanttien ja interferonien farmakologisten keskinäisten vaikutusten parantaminen lisäaineilla
PCT/FI1998/000418 WO1998052594A1 (en) 1997-05-19 1998-05-18 Compositions for enhancing immunosuppressants' pharmaceutical activities

Publications (3)

Publication Number Publication Date
DE69812347D1 true DE69812347D1 (de) 2003-04-24
DE69812347T2 DE69812347T2 (de) 2004-02-19
DE69812347T9 DE69812347T9 (de) 2004-09-23

Family

ID=8548873

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69812347T Expired - Fee Related DE69812347T9 (de) 1997-05-19 1998-05-18 Zusammensetzungen zur verstärkung der pharmakologischen aktivität von immunosuppressiva

Country Status (7)

Country Link
EP (1) EP0981359B1 (de)
JP (1) JP2001526675A (de)
AT (1) ATE234624T1 (de)
AU (1) AU7435298A (de)
DE (1) DE69812347T9 (de)
FI (1) FI104363B (de)
WO (1) WO1998052594A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20021774A (fi) * 2002-10-07 2004-04-08 Dmitry Aleksandrovich Dolgikh Peptidit ja yhdistelmäproteiinit, jotka jäljittelevät interferonien antiviraalia ja kasvua estävää toimintaa
CA2514061A1 (en) * 2003-02-14 2004-09-02 Combinatorx, Incorporated Combination therapy for the treatment of immunoinflammatory disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5183490A (en) * 1989-03-02 1990-09-26 University Of Florida Composition for the inhibition of tumors and for the non-cytotoxic inhibition of replication of viruses
CN1090510A (zh) * 1992-10-30 1994-08-10 佛罗里达大学 干扰素-τ组成物及其用途
FR2706772A1 (en) * 1993-06-22 1994-12-30 Vacsyn Sa Prevention and treatment of septic syndrome with an immunosuppressant, in particular cyclosporin.

Also Published As

Publication number Publication date
DE69812347T9 (de) 2004-09-23
FI972121A (fi) 1998-11-20
JP2001526675A (ja) 2001-12-18
FI972121A0 (fi) 1997-05-19
WO1998052594A1 (en) 1998-11-26
EP0981359A1 (de) 2000-03-01
EP0981359B1 (de) 2003-03-19
AU7435298A (en) 1998-12-11
DE69812347T2 (de) 2004-02-19
FI104363B (fi) 2000-01-14
ATE234624T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
ATE196475T1 (de) Auf histatin basierende, gegen pilze und bakterien gerichtete peptide
WO2002043746A3 (en) Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
DE60100740D1 (de) Verwendung von thrombin-derivierten peptiden zur therapie von kardiovaskuläre krankheiten
FR2757521B1 (fr) Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
WO2003089456A3 (en) Peptide inhibitors of protein kinase c
HK1014191A1 (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
DK1007566T3 (da) Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf
DE69929188D1 (de) Lysin enthaltende peptide zur behandlung von herzkrankheiten
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
DE60326723D1 (de) Verwendung von zusammensetzungen mit der biologischen aktivität der vasoaktiven intestinalen peptide zur behandlung von sarcoidose
DE50010519D1 (de) Pharmazeutische Zusammensetzungen zur Therapie der Herzinsuffizienz
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
DE69812347D1 (de) Zusammensetzungen zur verstärkung der pharmakologischen aktivität von immunosuppressiva
MXPA02005069A (es) Agentes de enlace especificos para t3 y metodos para su uso.
WO2004050685A3 (en) Antifungal therapeutic agents
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
DE69738600D1 (de) Neuroaktive peptide
DE69829995D1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
RU2008125167A (ru) Терапевтическое средство для ускоренного заживления кожи, содержащее в качестве активного ингредиента дезацил-грелин и его производные
DE60239705D1 (de) Thrombin-derivierten peptiden zur förderung von herzgewebsreparatur
CA2404696A1 (en) Medicament containing tissue inhibitor of metalloproteinases-2 (timp-2) as an osteoanabolically active substance
JP7475051B2 (ja) 新規化合物及びそれを含む血管新生剤
WO2002012336A3 (en) TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE
DK1368050T3 (da) Virusafledte antimikrobielle peptider

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee